Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377624 · ClinicalTrials.gov registry record · Phase 3
HUPS: Hyalgan Use in Painful Shoulder
A Phase 3 study, sponsored by Sanofi.
- Completed
- Registry status
- Phase 3
- Development phase
- 602
- Enrollment target
NCT00377624 is a Phase 3 study that has completed, run by Sanofi. The registered enrollment target is 602 participants.
The verdict
NCT00377624, a Phase 3 study, has completed, sponsored by Sanofi.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 602 participants
- Enrollment target
Study Summary
Three-arm, parallel, double-blind, masked observer, randomized, PB-Saline controlled clinical trial. In order to avoid problems in the interpretation of the final results due to disparate enrollment from various centers, the number of patients enrolled per site will be the same per site. Study patients will be randomized to receive either 20 mg sodium hyaluronate, 3 i.a. sodium hyaluronate injections, followed by 2 PBSaline mock i.a. injections or 5 i.a. PB-Saline control injections. One investigator will administer the injection and the joint assessor will be blinded to the study. The anterior or posterior approach for the shoulder injection will be used.
Interventions
- DRUG sodium hyaluronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377624
The ClinicalTrials.gov registry entry for NCT00377624 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which sodium hyaluronate is the first listed.
NCT00377624 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377624 about?
NCT00377624 is a clinical study titled "HUPS: Hyalgan Use in Painful Shoulder". Three-arm, parallel, double-blind, masked observer, randomized, PB-Saline controlled clinical trial. In order to avoid problems in the interpretation of the final results due to disparate enrollment from various centers, the number of patients enrolled per site will be the same per site. Study patie...
What is the current status of trial NCT00377624?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 602 participants. The study started on 2002-01. Estimated completion is 2004-09.
What interventions are being tested in trial NCT00377624?
The interventions under investigation include: sodium hyaluronate (DRUG).
Who is sponsoring clinical trial NCT00377624?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.